Case Studies #4, #5, #6: Relapsed Myeloma, Treatment for Relapsed Myeloma, Drugs in Development

Tiffany Richards, RN, MS, ANP-C
Beth Faiman, PhD , MSN, APRN-BC, AOCN® 

Start at page 64

Previous Post
IMWG Conference Series - Copenhagen 2016: What is the impact of the new diagnostic criteria?
Next Post
NLB 2016: Case #2, 3 Bone Health, Renal Health, 1+Prior Therapies, Immunotherapy, Clonal Evolution

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.